NEUROPHET
About:
NEUROPHET is a medical SW company using advanced neuroscience and AI technologies for better brain treatment.
Website: http://www.neurophet.com
Top Investors: TIPS Program, Mirae Asset Securities, SBI Investment, FuturePlay, Industrial Bank of Korea
Description:
Neurophet produces solutions based on Segengine, the company’s own technology that automatically segments brain magnetic resonance (MR) images into 107 regions within a minute.
Total Funding Amount:
48B KRW
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Gangneung, Kangwon-do, South Korea
Founded Date:
2016-03-14
Founders:
Donghyeon Kim, Junkil Been
Number of Employees:
51-100
Last Funding Date:
2023-11-07
IPO Status:
Private
© 2024 MyAiNote.com